TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
33,85Â US$
0,00%
(0,00) 1D
6 tet, 11:51:40 p.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për TKPHF...
Kapitalizimi i tregut
59,62Â mld
Vëllimi mesatar
2,49 mijë
Vëllimi
0,00
Maksimumi 52-javor
39,20Â US$
Minimumi 52-javor
26,33Â US$
Beta
-2,60
Aksionet në qarkullim
1,60Â mld
Numri i punonjësve
47 mijë
Kapitalizimi i tregut
59,62Â mld
Vëllimi mesatar
2,49 mijë
Vëllimi
0,00
Maksimumi 52-javor
39,20Â US$
Minimumi 52-javor
26,33Â US$
Beta
-2,60
Aksionet në qarkullim
1,60Â mld
Numri i punonjësve
47 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ad-hoc-news.de
·
5 orë më parë
Takeda stock pre-market at EUR 16.55
Profili
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Rreth Takeda Pharmaceutical Co Ltd
Drejtori ekzekutivChristophe Weber | Christophe Weber
Punonjësit47 mijë
Themeluar më12 qer 1781
Selia-
Sektori-
Uebsajtitakeda.com